Harry Cassin
Publisher and Editor
Andy Spalding
Senior Editor
Jessica Tillipman
Senior Editor
Bill Steinman
Senior Editor
Richard L. Cassin
Editor at Large
Elizabeth K. Spahn
Editor Emeritus
Cody Worthington
Contributing Editor
Julie DiMauro
Contributing Editor
Thomas Fox
Contributing Editor
Marc Alain Bohn
Contributing Editor
Bill Waite
Contributing Editor
Shruti J. Shah
Contributing Editor
Russell A. Stamets
Contributing Editor
Richard Bistrong
Contributing Editor
Eric Carlson
Contributing Editor
An executive at Swiss pharma Novartis pleaded guilty in a bribery prosecution in Poland, the company has confirmed.
Poland’s anti-corruption bureau charged two women with bribery. Prosecutors said they gave a health fund official a tourist trip worth more than $1,000 in exchange for backing the sale of a particular drug, Reuters said.… Continue Reading
GlaxoSmithKline said Tuesday it is investigating allegations of corrupt payments in the United Arab Emirates.
The UK’s biggest pharma confirmed the investigation following allegations of improper payments set out in a whistleblower’s email sent to its top management Monday, Reuters said.… Continue Reading
Sanofi said Monday it has self reported the allegations to the U.S.… Continue Reading
A court in China fined UK pharma giant GlaxoSmithKline $490 million Friday following a conviction for bribery.
GSK’s former head of China operations, Mark Reilly, was given a three-year prison sentence that was suspended, the BBC said.… Continue Reading
Minnesota-based Image Sensing Systems said the DOJ has “closed its inquiry” into potential Foreign Corrupt Practices Act violations and the SEC has also closed its investigation.
The company said last week the DOJ decision not to bring an enforcement action cited its “voluntary disclosure, thorough investigation, cooperation and voluntary enhancements to its compliance program.”… Continue Reading
A Russia subsidiary of Palo Alto-based Hewlett Packard Company pleaded guilty Thursday in federal court in San Francisco to conspiracy and substantive violations of the anti-bribery and accounting provisions of the Foreign Corrupt Practices Act.… Continue Reading
Image courtesy of AlstomThe trial of a UK subsidiary of Paris-based Alstom started Tuesday, with the Serious Fraud Office alleging in filings that the company paid $8.5 million in bribes for contracts in India, Poland, and Tunisia.… Continue Reading
A former CEO of red-light camera operator Redflex Traffic Systems was indicted Wednesday on charges she and a top Chicago official conspired to rig the traffic camera business for a decade.… Continue Reading
The Serious Fraud Office said Thursday it has started criminal proceedings “against an Alstom company in the UK by written charge.”
Alstom Network UK Ltd, formerly called Alstom International Ltd, a UK subsidiary of Alstom, was charged with three corruption offenses, and three counts of conspiracy to corrupt.… Continue Reading
GlaxoSmith Kline PLC is under investigation by the UK Serious Fraud Office for possible criminal violations, the pharma said Tuesday.
In a two-sentence statement, UK-based GSK said it had been informed by the SFO of a formal criminal investigation into GSK’s commercial practices.… Continue Reading
Chinese police Wednesday charged the British former boss of GlaxoSmithKline’s China unit and two other company executives with corruption for bribing health officials and doctors.
A Ministry of Public Security official said in Beijing that Mark Reilly (pictured) and two Chinese executives, Zhang Guowei and Zhao Hongyan, offered bribes to hospital personnel and doctors to boost GSK’s sales.… Continue Reading
Sir Andrew Witty, CEO of GlaxoSmithKline, courtesy of Wellcome Trust via YouTubeGlaxoSmithKline is facing a criminal investigation in Poland for allegedly bribing doctors there between 2010 and 2012.
The BBC’s “Panorama” program reported Monday that the British pharma is accused of paying doctors to promote GSK’s asthma drug Seretide.… Continue Reading
